Corcept Therapeutics
This role involves collaborating with cross-functional teams to author, edit, and format high-quality clinical and regulatory documents that support the development and regulatory requirements of clinical programs. The position requires managing medical writing timelines, leading comment resolution, and overseeing vendors to ensure deliverables meet business needs and compliance standards. The role also includes maintaining subject area expertise and refining medical writing processes to support the company's investigational products and disease indications.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
1998
Corcept Therapeutics is a biopharmaceutical company that discovers and develops medicines that modulate the glucocorticoid receptor to treat disorders driven by excess cortisol. The company commercialized Korlym (mifepristone) for hyperglycemia secondary to endogenous Cushing’s syndrome and is advancing next‑generation, selective GR modulators (for example, relacorilant) through clinical development. Corcept combines translational science, clinical trials, and commercial capabilities to target endocrine and oncology indications where cortisol signaling contributes to disease. The company is headquartered in Menlo Park, California.
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT
8 hours ago
REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026
1 day ago
Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements
7 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Corcept Therapeutics.
51% above the average for this role
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm – Company Announcement - FT.com
12 hours ago
Associate Director, Medical Writing
Summit Therapeutics,
Senior Medical Writer
ICON plc
Senior Manager, Global Scientific and Regulatory Documentation
Bristol Myers Squibb
Director, Global Medical Writing
Deciphera Pharmaceuticals
Principal Medical Writer (Regulatory focus) - Sponsor-dedicated - Poland, Belgium, Netherlands, Spain
Syneos Health
Principal Medical Writer / Senior Medical Writer - US - FSP
Parexel